Articles By Jonathan Weiss
-
Type 1 Diabetes Risk Linked To Timing Of Solid Food Introduction To Infants
When children were introduced to solid food before four months or after six, their risk of type 1 diabetes increased. -
Lawson Dairy Farm In Vermont Shut Down By FDA And Department Of Justice For Illegal Drug Use In Cows
The government has taken action against Lawson Farms for the illegal and inappropriate usage of antibiotics and other drugs in animals. -
Cutting Edge Cancer Therapy From Immunocore Receives $212M In Funding From GSK
GSK is committing millions to the development of Immunocore's ImmTACs to attack far more cancer targets than current technology allows for. -
GSK Melanoma Drug Combination Submitted To FDA In Whirlwind Attempt To Gain Fast Approval
GSK hopes to sidestep the normal FDA approval process by submitting mid-stage clinical data for a combination of already approved melanoma drugs. -
New And Cheaper IVF Technique Could Bring More Babies Into Reach For Couples In Need
Couples who previously struggled to have children due to high treatment costs now have hope with a new and cheaper IVF technique. -
Experimental Psoriasis Drug Secukinumab Clobbers Current Treatment, Enbrel, In Clinical Trials
The experimental psoriasis drug is the first to block a newly discovered mediator in autoimmune diseases. -
Drug Addiction Treatment For Opioid Dependence, Zubsolv, Approved By FDA
A smaller, mint-flavored pill that dissolves under the tongue quickly, Zubsolv is set to help the millions in the US that suffer from addiction to pain killers and other opioid-derived drugs. -
Monthly Injections Instead Of Daily Pills For HIV Treatment Show Promise In Early Trials
A monthly or quarterly shot could replace daily medication regimens in patients with HIV, helping them treat their infections more effectively. -
Chronic Lymphocytic Leukemia Drug, Obinutuzumab, From Genentech Now Under FDA Priority Review
The leukemia drug, obinutuzumab, causes the killing of lymphoma cells in two ways, and is now on a fast track toward FDA approval. -
HIV Possibly Cured In Two Boston Patients After Bone Marrow Transplant [VIDEO]
Although doctors and researchers are cautious about calling them "cured," two Boston patients appear to have no sign of HIV infection weeks after ceasing their HIV medication treatments. -
Experimental Oral Alzheimer’s Drug, TTP488, Prepares For Late-Stage Phase III Clinical Trial
The drug, TTP488, has already been granted "fast track" status by the FDA and is set to begin Phase III clinical trials after finalizing the study design with the FDA. -
Schizophrenia Drug Latuda Given FDA Approval To Treat Depression From Bipolar Disorder
Latuda, a drug previously used to treat schizophrenia, has shown promise in clinical trials on major depression from bipolar disorder, earning approval by the FDA.
